Advisory Board on Radiation and Worker Health (ABRWH or Advisory Board), National Institute for Occupational Safety and Health (NIOSH), 5841-5842 [E9-2165]
Download as PDF
<![CDATA[
Federal Register / Vol. 74, No. 20 / Monday, February 2, 2009 / Notices
certain requirements for ATSDR and for
the U.S. Environmental Protection
Agency (EPA) with regard to hazardous
substances most commonly found at
facilities on the CERCLA National
Priorities List (NPL). One such
requirement directs the ATSDR
Administrator to prepare toxicological
profiles for each substance included on
the priority lists of hazardous
substances. These lists identify 275
hazardous substances determined by
ATSDR and by U.S. EPA to pose the
most significant potential threat to
human health. The availability of the
revised lists of the 275 priority
substances was announced in the
Federal Register on March 6, 2008 (73
FR 12178). For previous versions of the
lists of substances, see Federal Register
notices dated April 17, 1987 (52 FR
12866); October 20, 1988 (53 FR 41280);
October 26, 1989 (54 FR 43619); October
17, 1990 (55 FR 42067); October 17,
1991 (56 FR 52166); October 28, 1992
(57 FR 48801); February 28, 1994 (59 FR
9486); April 29, 1996 (61 FR 18744;
November 17, 1997 (62 FR 61332);
October 21, 1999 (64 FR 56792); October
25, 2001 (66 FR 54014); November 7,
2003 (68 FR 63098) and December 7,
2005 (70 FR 72840).
Notice of the availability of
toxicological profile drafts for public
review and comment was published in
the Federal Register on October 18,
2006, (71 FR 61471), with notice of a 90day public comment period for each
profile, starting from the actual release
date. Following the close of the
comment period, chemical-specific
comments were addressed, and, where
appropriate, changes were incorporated
into each profile. The public comments
and other data submitted in response to
the Federal Register notices carry the
docket control number ATSDR–225.
This material is available for public
inspection at the Division of Toxicology
and Environmental Medicine, Agency
5841
for Toxic Substances and Disease
Registry, 4700 Buford Highway,
Building 106, Second Floor, Chamblee,
Georgia 30341 between 8 a.m. and 4:30
p.m., Monday through Friday, except
legal holidays.
Availability
This notice announces the availability
of seven toxicological profiles of priority
hazardous substances: six updated final
toxicological profiles and one new final
toxicological profile. This is the 20th set
of toxicological profiles that ATSDR has
compiled.
The following toxicological profiles
are now available through the U.S.
Department of Commerce, National
Technical Information Service (NTIS),
5285 Port Royal Road, Springfield,
Virginia 22161, telephone 1–800–553–
6847. These profiles are available for a
fee as determined by NTIS.
Twentieth Set:
Toxicological profile
NTIS order No.
CAS No.
Aluminum (Update) ...........................................................................................................................................
Cresols (Update) ..............................................................................................................................................
Diazinon (Update) .............................................................................................................................................
Dichloropropenes (UPDATE) ...........................................................................................................................
PB2009–100001
PB2009–100002
PB2009–100003
PB2009–100004
5. Guthion* ............................................................................................................................................................
6. Phenols (Update) ..............................................................................................................................................
7. 1,1,2,2-Tetrachloroethane (Update) .................................................................................................................
PB2009–100005
PB2009–100007
PB2009–100008
007429–90–5
001319–77–3
000333–41–5
000563–58–6
000563–54–2
000563–57–5
000078–88–6
010061–01–5
010061–02–6
000542–75–6
000086–50–0
000108–95–2
000079–34–5
1.
2.
3.
4.
* Denotes new profile.
Dated: January 28, 2009.
Ken Rose,
Director, Office of Policy, Planning and
Evaluation, National Center for
Environmental Health/Agency for Toxic
Substances and Disease Registry.
[FR Doc. E9–2163 Filed 1–30–09; 8:45 am]
BILLING CODE 4163–70–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
dwashington3 on PROD1PC60 with NOTICES
Centers for Disease Control and
Prevention
Advisory Board on Radiation and
Worker Health (ABRWH or Advisory
Board), National Institute for
Occupational Safety and Health
(NIOSH)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), and pursuant to the
requirements of 42 CFR 83.15(a), the
Centers for Disease Control and
VerDate Nov<24>2008
15:03 Jan 30, 2009
Jkt 217001
Prevention (CDC), announces the
following meeting of the
aforementioned committee:
Board Meeting Times and Dates:
1 p.m.–5:30 p.m., February 17, 2009.
9 a.m.–5 p.m., February 18, 2009.
9 a.m.–4:30 p.m., February 19, 2009.
Public Comment Times and Dates:
6 p.m.–7 p.m., February 17, 2009.
7 p.m.–8 p.m., February 18, 2009.
Place: Doubletree Hotel Albuquerque,
201 Marquette Avenue Northwest,
Albuquerque, NM 87102, Phone: 505–
247–3344; Fax: 505–247–7025. Audio
Conference Call via FTS Conferencing.
The USA toll free dial in number is
1–866–659–0537 with a pass code of
9933701.
Status: Open to the public, limited
only by the space available. The meeting
space accommodates approximately 100
people.
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation
Program (EEOICP) Act of 2000 to advise
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
the President on a variety of policy and
technical functions required to
implement and effectively manage the
new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines
which have been promulgated by the
Department of Health and Human
Services (HHS) as a final rule, advice on
methods of dose reconstruction which
have also been promulgated by HHS as
a final rule, advice on the scientific
validity and quality of dose estimation
and reconstruction efforts being
performed for purposes of the
compensation program, and advice on
petitions to add classes of workers to the
Special Exposure Cohort (SEC).
In December 2000, the President
delegated responsibility for funding,
staffing, and operating the Advisory
Board to HHS, which subsequently
delegated this authority to the CDC.
NIOSH implements this responsibility
for CDC. The charter was issued on
E:\FR\FM\02FEN1.SGM
02FEN1
dwashington3 on PROD1PC60 with NOTICES
5842
Federal Register / Vol. 74, No. 20 / Monday, February 2, 2009 / Notices
August 3, 2001, renewed at appropriate
intervals, and will expire on August 3,
2009.
Purpose: This Advisory Board is
charged with (a) Providing advice to the
Secretary, HHS, on the development of
guidelines under Executive Order
13179; (b) providing advice to the
Secretary, HHS, on the scientific
validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advise the Secretary on
whether there is a class of employees at
any Department of Energy facility who
were exposed to radiation but for whom
it is not feasible to estimate their
radiation dose, and on whether there is
reasonable likelihood that such
radiation doses may have endangered
the health of members of this class.
Matters to be Discussed: The agenda
for the Advisory Board meeting
includes: NIOSH Program Status
Update; NIOSH and Department of
Energy (DOE) Security Plans;
Department of Labor (DOL) Update;
Special Exposure Cohort (SEC) Petitions
for: Los Alamos National Laboratory,
Westinghouse Atomic Power
Development, Tyson Valley Powder
Farm, General Steel Industries, Hood
Building (Massachusetts Institute of
Technology), and Blockson Chemical;
SC&A New Technical Support Contract;
Special Exposure Cohort (SEC) Petition
Status Updates; Science Update; Work
Group reports; Subcommittee on Dose
Reconstruction Reviews Report;
Subcommittee on Procedures Reviews
and Board Future Plans and Meetings.
The agenda is subject to change as
priorities dictate.
In the event an individual cannot
attend, written comments may be
submitted according to the policy
provided below. Any written comments
received will be provided at the meeting
and should be submitted to the contact
person below well in advance of the
meeting.
Policy on Redaction of Board Meeting
Transcripts (Public Comment), (1) If a
person making a comment gives his or
her name, no attempt will be made to
redact that name. (2) NIOSH will take
reasonable steps to ensure that
individuals making public comment are
aware of the fact that their comments
(including their name, if provided) will
appear in a transcript of the meeting
posted on a public Web site. Such
reasonable steps include: (a) A
statement read at the start of each public
comment period stating that transcripts
will be posted and names of speakers
will not be redacted; (b) A printed copy
of the statement mentioned in (a) above
will be displayed on the table where
VerDate Nov<24>2008
15:03 Jan 30, 2009
Jkt 217001
individuals sign up to make public
comment; (c) A statement such as
outlined in (a) above will also appear
with the agenda for a Board Meeting
when it is posted on the NIOSH Web
site; (d) A statement such as in (a) above
will appear in the Federal Register
Notice that announces Board and
Subcommittee meetings. (3) If an
individual in making a statement
reveals personal information (e.g.,
medical information) about themselves
that information will not usually be
redacted. The NIOSH FOIA coordinator
will, however, review such revelations
in accordance with the Freedom of
Information Act and the Federal
Advisory Committee Act and if deemed
appropriate, will redact such
information. (4) All disclosures of
information concerning third parties
will be redacted. (5) If it comes to the
attention of the DFO that an individual
wishes to share information with the
Board but objects to doing so in a public
forum, the DFO will work with that
individual, in accordance with the
Federal Advisory Committee Act, to
find a way that the Board can hear such
comments.
CONTACT PERSON FOR MORE INFORMATION:
Theodore Katz, M.P.A., Executive
Secretary, NIOSH, CDC, 1600 Clifton
Road, MS E–20, Atlanta, GA 30333,
Telephone (513) 533–6800, Toll Free 1
(800) CDC–INFO, E-mail ocas@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both CDC
and the Agency for Toxic Substances
and Disease Registry.
Dated: January 22, 2009.
Lorenzo J. Falgiano,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. E9–2165 Filed 1–30–09; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Committee on Immunization
Practices (ACIP)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting of the
aforementioned committee:
Times and Dates:
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
8 a.m.–5 p.m., February 25, 2009.
8 a.m.–5 p.m., February 26, 2009.
Place: Centers for Disease Control and
Prevention, Tom Harkin Global
Communications Center, 1600 Clifton
Road, NE., Building 19, Kent ‘‘Oz’’
Nelson Auditorium, Atlanta, Georgia
30333.
Status: Open to the public, limited
only by the space available.
Purpose: The committee is charged
with advising the Director, CDC, on the
appropriate uses of immunizing agents.
In addition, under 42 U.S.C. 1396s, the
committee is mandated to establish and
periodically review and, as appropriate,
revise the list of vaccines for
administration to vaccine-eligible
children through the Vaccines for
Children (VFC) program, along with
schedules regarding the appropriate
periodicity, dosage, and
contraindications applicable to the
vaccines.
Matters to be Discussed: The agenda
will include discussions on Anthrax;
Hepatitis Vaccines; Measles, Mumps
and Rubella; Influenza Vaccine;
Pneumococcal Vaccines; Rabies
Vaccine; General Recommendations;
Human Papillomavirus Vaccines;
Herpes Zoster; Meningococcal Vaccine;
MMRV Vaccine Safety; Pertussis; Polio
Vaccine; Vaccine Safety; Vaccine
Supply; Vaccination of Immigrants and
refugees; Yellow Fever. Agenda items
are subject to change as priorities
dictate.
Contact Person for More Information:
Antonette Hill, Immunization Services
Division, National Center for
Immunization and Respiratory Diseases,
CDC, 1600 Clifton Road, NE., (E–05),
Atlanta, Georgia 30333, telephone 404/
639–8836, fax 404/639–8905.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both CDC
and the Agency for Toxic Substances
and Disease Registry.
Dated: January 22, 2009.
Lorenzo J. Falgiano,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. E9–2164 Filed 1–30–09; 8:45 am]
BILLING CODE 4160–18–P
E:\FR\FM\02FEN1.SGM
02FEN1
]]>Agencies
[Federal Register Volume 74, Number 20 (Monday, February 2, 2009)]
[Notices]
[Pages 5841-5842]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-2165]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Board on Radiation and Worker Health (ABRWH or Advisory
Board), National Institute for Occupational Safety and Health (NIOSH)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), and pursuant to the requirements of 42
CFR 83.15(a), the Centers for Disease Control and Prevention (CDC),
announces the following meeting of the aforementioned committee:
Board Meeting Times and Dates:
1 p.m.-5:30 p.m., February 17, 2009.
9 a.m.-5 p.m., February 18, 2009.
9 a.m.-4:30 p.m., February 19, 2009.
Public Comment Times and Dates:
6 p.m.-7 p.m., February 17, 2009.
7 p.m.-8 p.m., February 18, 2009.
Place: Doubletree Hotel Albuquerque, 201 Marquette Avenue
Northwest, Albuquerque, NM 87102, Phone: 505-247-3344; Fax: 505-247-
7025. Audio Conference Call via FTS Conferencing. The USA toll free
dial in number is 1-866-659-0537 with a pass code of 9933701.
Status: Open to the public, limited only by the space available.
The meeting space accommodates approximately 100 people.
Background: The Advisory Board was established under the Energy
Employees Occupational Illness Compensation Program (EEOICP) Act of
2000 to advise the President on a variety of policy and technical
functions required to implement and effectively manage the new
compensation program. Key functions of the Advisory Board include
providing advice on the development of probability of causation
guidelines which have been promulgated by the Department of Health and
Human Services (HHS) as a final rule, advice on methods of dose
reconstruction which have also been promulgated by HHS as a final rule,
advice on the scientific validity and quality of dose estimation and
reconstruction efforts being performed for purposes of the compensation
program, and advice on petitions to add classes of workers to the
Special Exposure Cohort (SEC).
In December 2000, the President delegated responsibility for
funding, staffing, and operating the Advisory Board to HHS, which
subsequently delegated this authority to the CDC. NIOSH implements this
responsibility for CDC. The charter was issued on
[[Page 5842]]
August 3, 2001, renewed at appropriate intervals, and will expire on
August 3, 2009.
Purpose: This Advisory Board is charged with (a) Providing advice
to the Secretary, HHS, on the development of guidelines under Executive
Order 13179; (b) providing advice to the Secretary, HHS, on the
scientific validity and quality of dose reconstruction efforts
performed for this program; and (c) upon request by the Secretary, HHS,
advise the Secretary on whether there is a class of employees at any
Department of Energy facility who were exposed to radiation but for
whom it is not feasible to estimate their radiation dose, and on
whether there is reasonable likelihood that such radiation doses may
have endangered the health of members of this class.
Matters to be Discussed: The agenda for the Advisory Board meeting
includes: NIOSH Program Status Update; NIOSH and Department of Energy
(DOE) Security Plans; Department of Labor (DOL) Update; Special
Exposure Cohort (SEC) Petitions for: Los Alamos National Laboratory,
Westinghouse Atomic Power Development, Tyson Valley Powder Farm,
General Steel Industries, Hood Building (Massachusetts Institute of
Technology), and Blockson Chemical; SC&A New Technical Support
Contract; Special Exposure Cohort (SEC) Petition Status Updates;
Science Update; Work Group reports; Subcommittee on Dose Reconstruction
Reviews Report; Subcommittee on Procedures Reviews and Board Future
Plans and Meetings.
The agenda is subject to change as priorities dictate.
In the event an individual cannot attend, written comments may be
submitted according to the policy provided below. Any written comments
received will be provided at the meeting and should be submitted to the
contact person below well in advance of the meeting.
Policy on Redaction of Board Meeting Transcripts (Public Comment),
(1) If a person making a comment gives his or her name, no attempt will
be made to redact that name. (2) NIOSH will take reasonable steps to
ensure that individuals making public comment are aware of the fact
that their comments (including their name, if provided) will appear in
a transcript of the meeting posted on a public Web site. Such
reasonable steps include: (a) A statement read at the start of each
public comment period stating that transcripts will be posted and names
of speakers will not be redacted; (b) A printed copy of the statement
mentioned in (a) above will be displayed on the table where individuals
sign up to make public comment; (c) A statement such as outlined in (a)
above will also appear with the agenda for a Board Meeting when it is
posted on the NIOSH Web site; (d) A statement such as in (a) above will
appear in the Federal Register Notice that announces Board and
Subcommittee meetings. (3) If an individual in making a statement
reveals personal information (e.g., medical information) about
themselves that information will not usually be redacted. The NIOSH
FOIA coordinator will, however, review such revelations in accordance
with the Freedom of Information Act and the Federal Advisory Committee
Act and if deemed appropriate, will redact such information. (4) All
disclosures of information concerning third parties will be redacted.
(5) If it comes to the attention of the DFO that an individual wishes
to share information with the Board but objects to doing so in a public
forum, the DFO will work with that individual, in accordance with the
Federal Advisory Committee Act, to find a way that the Board can hear
such comments.
Contact Person for More Information: Theodore Katz, M.P.A., Executive
Secretary, NIOSH, CDC, 1600 Clifton Road, MS E-20, Atlanta, GA 30333,
Telephone (513) 533-6800, Toll Free 1 (800) CDC-INFO, E-mail
ocas@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both CDC and the Agency for Toxic Substances and Disease Registry.
Dated: January 22, 2009.
Lorenzo J. Falgiano,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. E9-2165 Filed 1-30-09; 8:45 am]
BILLING CODE 4163-18-P
